Columbia Laboratories Inc Share Price - CBRX, RNS News, Articles, Share Price Quotes, Charts, & Stock Market information(NASDAQ:CBRX, CBRX)

Columbia Laboratories Inc
www.columbialabs.com

Columbia Laboratories' mission is to build a specialty women's healthcare business with a competitive advantage in the United States. We promote four prescription pharmaceutical products in the U.S., including CRINONE® 8% and PROCHIEVE® 8% progesterone gels, two brands of our bioadhesive natural progesterone vaginal gel used as part of an Assisted Reproductive Technology treatment for infertility and pregnancy support. We derive additional revenues through marketing agreements for four other products.

News

All Columbia Laboratories Inc News ►

Recent Sector News

Dow suffers on Greece fears, Hewlett-Packard in focus

U.S. equity markets fell Wednesday afternoon on concerns that Greece could exit the euro as the region’s gather for an informal meeting.
Dow points lower ahead of eurozone meeting, Facebook, Dell in focus

U.S. equity markets looked set to open lower Wednesday morning ahead of a meeting of European Union leaders amid continued worries over the eurozone debt crisis.
Q1 gold demand underpinned by China, Central Banks and ETFs

Global gold demand in the first quarter of 2012 was 1,097.6 tonnes, down 5 percent from the high demand levels seen a year earlier, according to the World Gold Council.
Medgenics cleared by FDA to begin Phase IIb clinical trials for EPODURE; shares up

Biopharmaceutical company Medgenics (LON:MEDG, AMEX:MDGN) achieved a major milestone today - with clearance to begin a phase IIb trial of EPODURE to treat anaemia in kidney failure patients.
Facebook boosts public offering by 25%

Social network site Facebook Wednesday increased the size of its initial public offering by almost 25 per cent as it could raise as much as $16 billion on strong investor demand for its market debut.
Snipp plans ambitious growth as mobile marketing takes off

Mobile marketing company Snipp (CVE:SPN) (TSX.V:SPN), which recently listed on the TSX Venture Exchange, is now seeking a listing on the OTC exchange as it continues to grow in a space that is seeing more and more traction from companies looking to boost their marketing efforts.